Psychiatr News May 18, 2007
Volume 42, Number 10, page 42
© 2007 American Psychiatric Association
Interpersonal Therapy Promising as Maintenance Treatment
Stephanie Whyche
There's good news for some women who experience recurrent depression but
can't or won't take an antidepressant: sustained remission of symptoms may be
possible with "booster" doses of psychotherapy alone.
An outpatient, maintenance regimen of interpersonal psychotherapy
(IPT)—without concomitant antidepressant medication—appears to be
as beneficial for some women who suffer repeated episodes of depression as
treatment with antidepressants alone or psychotherapy and antidepressants
together, according to investigators in the departments of psychiatry and
psychology at the University of Pittsburgh School of Medicine and the Western
Psychiatric Institute and Clinic.
Indeed, the investigators said that their data suggest that even
"relatively infrequent contact, in the form of either booster sessions
or monthly treatment sessions [of IPT], may be sufficient to protect the
majority of individuals who are able to achieve remission with psychotherapy
alone in the subsequent one to two years."
The study, reported in the May American Journal of Psychiatry,
enrolled 233 women aged 20 to 60 between 1992 and April 1999. Among the
eligibility criteria were that the women had to be experiencing at least their
second episode of unipolar depression and were willing to consider a
nonpharmacologic approach leading up to and during maintenance treatment.
Once the subjects achieved remission with weekly IPT only—or if need
be, with weekly IPT and antidepressant therapy—they randomly were placed
into three groups in which they would receive booster doses of IPT either
weekly, twice monthly, or monthly for two years.
"Remission" was defined as having minimal or no symptoms for
three consecutive weeks as evidenced by a HAM-D score of 7 or less.
During the acute treatment phase, subjects who had not reached remission
with four IPT sessions in four weeks had their IPT sessions increased to twice
a week for four weeks. Further, the women who had not reached remission but
who had agreed to the option of pharmacologic treatment also had twice a week
IPT. Once remission of their symptoms was confirmed with a HAM-D score of 7 or
less for three continuous weeks, these women entered into a
"continuation phase" of up to 17 weeks. Only at the end of this
phase were they randomly assigned to the weekly, twice monthly, or monthly
maintenance IPT sessions for two years or until symptoms recurred.
Recurrence was defined as meeting the DSM-IV criteria for major
depression, as "confirmed by a senior psychiatrist who was not part of
the investigative team."
Of the women enrolled in the study, 131 ultimately achieved remission and
entered the IPT-only maintenance phase. Ninetynine women achieved remission of
their depression symptoms with IPT alone during the acute-treatment phase of
the trial, which spanned 12 to 24 weeks. Of these, only 19 (26 percent of the
74 women who were able to complete two years of maintenance treatment)
experienced a recurrence of depression.
"This rate is among the lowest observed to date in maintenance
treatment studies involving patients with established histories of
recurrence," wrote Ellen Frank Ph.D, and colleagues.
What does this mean for women and their clinicians? "Some women with
quite recurrent depression—about 50 percent—can achieve and
maintain remission with a depression-specific psychotherapy alone,"
Frank told Psychiatric News. "Particularly for women in the
childbearing years, this should be considered as a first-line treatment,
especially because among those who do not achieve remission with psychotherapy
alone, the remission rate is very high once medication is added."
Subjects who remained in the trial for the full two years were generally in
total remission throughout that period. Of the 90 women requiring a sequential
treatment of IPT and antidepressant therapy, only 32 (36 percent) sustained
that remission through a "continuation" phase and ultimately
qualified to enter the IPT-only maintenance phase. Of that group, 13 of the 26
who remained in maintenance suffered a recurrence of symptoms.
The study results "suggest that maintenance IPT, even at a frequency
of only one visit per month, is a good method of prophylaxis for women who can
achieve remission with IPT alone," the researchers concluded.
In their review of the literature, the investigators noted there is now a
solid body of evidence that shows long-term maintenance treatment of patients
with unipolar depression with full-dose medications is the most effective way
to sustain remission of symptoms. But for many patients, this is not the
preferred treatment. The authors pointed to data suggesting that more women
than men generally opt for nonpharmacologic intervention.
The authors explained that "because our goal was to study various
`doses' of IPT alone as a maintenance treatment, and because our participants
had entered the study with the hope of being treated and maintained
recurrence-free without medication, we attempted discontinuation of the SSRI
at the end of the [post-acute]continuation phase over a period of one to four
weeks. The SSRI was discontinued only after a careful discussion [with the
patient] of the potential risks of discontinuing medication and with careful
monitoring of patients. These participants continued to receive IPT alone for
four to six weeks to ensure that their remission was stable before they
entered into the experimental phase."
Those in the post-acute, continuation phase, who experienced an onset of
symptoms reflecting criteria of a major depression were deemed to have
"relapsed." They were withdrawn from the study and provided with
appropriate treatment intervention.
The investigators acknowledged that the major limitation in the study's
design was that it did not feature a "no-treatment" comparison
group. They considered it risky and "unethical" to include such a
study population.
They said that their results point to three conclusions: (1) when IPT alone
is effective in bringing about a remission of symptoms, it is also effective
as a maintenance treatment; (2) in the maintenance phase, IPT delivered at
weekly or twice-monthly intervals is no more effective in maintaining
remission than IPT delivered on a monthly basis; and (3) when IPT alone is not
effective in the acute treatment phase, it is generally not effective in
maintaining remission. Thus, for women who require combined treatment to
achieve remission, IPT alone cannot be recommended as a maintenance
treatment.
The study was supported by the National Institute of Mental Health.
"Randomized Trial of Weekly, Twice-Monthly, and Monthly
Interpersonal Psychotherapy as Maintenance Treatment for Women With Recurrent
Depression" is posted at
<http://ajp.psychiatryonline.org/cgi/content/full/164/5/761>.
Am J Psychiatry 2007 164 761[Abstract/Free Full Text]
Get information about faster international access.
Privacy Policy
Copyright © 2007
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
| 
